ENT devices are used for diagnosis, surgery and treatment of any kind of diseases related to ear, nose and throat and thereby correct the problems related to hearing, snoring, smelling or speaking. Diseases can include hear loss, chronic ear disease, airway stenosis, airway tumors, cancer, feeding and swallowing disorders, mastoiditis, voice disorders (Dysphonia), sinusitis and others. Some of the popular ENT devices available in the market are endoscopes, hearing aids, hearing implants, handheld surgical instruments, balloon sinus dilation devices, CO2 lasers, image-guided surgery systems, ear tubes, and voice prosthesis devices.
The top five companies covered are Sonova Holdings AG, William Demant Holdings A/S, Medtronic plc, KARLSTORZ GmbH & Co and Stryker Corporation. Sonova Holdings AG was the largest company in the ENT devices market in 2017.
The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.
The global ENT devices market was valued at around $90 billion in 2017. Asia Pacific was the largest region in the ENT devices market in 2017, accounting for nearly 35% of the market share. The USA was the largest country in the market in 2017, accounting for more than 21% market share.
Companies in the ENT device market are working towards constant innovation in design and technology to make these devices more user friendly and non-invasive. They are continuously investing funds and resources into R&D to increase the scope of their devices. For instance, Intersect ENT developed Propel Mometasone Furoate Implant (PMFI) to treat chronic sinusitis. It is a bio-absorbable steroid which is placed directly into the sinus mucosa. It controls the release of drugs and dissolves over time.